PFIZER - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 19 Sept 25, 2:16 pm

Technical Rating: 3.4

Here’s a detailed technical analysis of Pfizer Ltd (PFIZER)

📊 Trend Overview

Current Trend: The stock is in a neutral to mildly bearish phase, trading below its 50-DMA (₹5,255) but above its 200-DMA (₹5,059). This suggests indecision and lack of strong momentum.

52-Week Positioning: At 63.8% of its 52-week range (₹3,701 – ₹6,039), the stock is in the upper-middle zone, indicating partial recovery from lows but still below peak levels.

📈 Momentum Indicators

RSI (47.3): Slightly bearish. Below 50 implies weak buying interest, though not oversold.

MACD (-39.2): Bearish crossover. Confirms fading momentum and lack of short-term bullish signals.

Volume: Current volume (19.9K) is slightly above the 1-week average (17.7K), showing stable participation but no signs of accumulation.

📉 Chart Patterns & Moving Averages

Price Action: The stock has recently slipped below its 50-DMA and is hovering near the 200-DMA, forming a potential support base.

Support Levels

₹5,050–₹5,100 – near 200-DMA and recent swing low

₹4,900 – psychological support

Resistance Levels

₹5,255–₹5,300 – 50-DMA and short-term resistance

₹5,500–₹5,600 – previous consolidation zone

📌 Bollinger Bands

Price is near the middle band, with bands narrowing. This suggests low volatility and potential for a breakout or breakdown depending on volume and sentiment.

🎯 Entry & Exit Zones

Action Price Zone (₹) Rationale

Entry 5,050–5,100 Near 200-DMA, favorable risk-reward

Exit (Short) 5,255–5,300 Resistance zone, near 50-DMA

Exit (Long) 5,500–5,600 If breakout sustains above ₹5,300

🔍 Market Behavior

Trending: No, currently consolidating between key moving averages.

Consolidating: Yes, price is range-bound with neutral indicators.

Reversing: Not yet. MACD and RSI suggest continued indecision.

🧠 Summary

PFIZER is technically neutral, consolidating between its 50-DMA and 200-DMA. RSI and MACD show weak momentum, and volume is steady but not bullish. Traders may consider accumulating near ₹5,050 with tight stop-losses and watch for a breakout above ₹5,300 for confirmation of trend reversal.

Let me know if you’d like to explore pharma sector peers or dividend-focused setups next.

Edit in a page